신동우 교수
전문진료분야
췌장암, 담도암, 담낭암, 바터팽대부암, 췌장염, 췌장낭종, 담석증, 담낭 용종, 기타 췌장, 담낭, 담도 질환
전화 예약
1577-1801
기본정보
학력
2018.09 ~ 2020.08서울대학교 대학원 의학 박사 2016.08United States Medical Licensing Examination(USMLE) pass 2014.09 ~ 2016.08경북대학교 대학원 의학 석사 2003.03 ~ 2009.02제주대학교 의과대학 의학사 |
경력
2026.09 ~ 한림대학교성심병원 소화기내과 부교수 2022.03 ~ 2026.08한림대학교성심병원 소화기내과 조교수 2020.01 ~ 2020.02계명대학교동산병원 소화기내과 조교수 2019.03 ~ 2019.12분당서울대학교병원 소화기내과 진료전문의 2017.05 ~ 2019.02분당서울대학교병원 소화기내과 임상강사 2014.04 ~ 2017.04병무청 중앙병역판정검사소 병역판정검사전담의사 |
학회활동
2026 ~ 2028대한소화기내시경학회 경기지회 교육위원회 위원 2026 ~ 2028대한소화기내시경학회 경기지회 학술위원회 위원 2022 ~ 2028대한소화기암연구학회 췌장담도암연구회 위원 2026 ~ 2028대한소화기암연구학회 편집위원회 위원 2026 ~ 2028대한췌장담도학회 보험위원회 위원 2026 ~ 2028대한췌장담도학회 췌장담도질환연구회 위원 2024 ~ 2026대한소화기내시경학회 경기지회 학술위원회 위원 2024 ~ 2026대한소화기내시경학회 교육수련위원회 위원 2024 ~ 2026대한소화기학회 편집위원회 위원 2024 ~ 2026대한소화기학회 학술위원회 위원 2024 ~ 2026대한췌장담도학회 기획위원회 위원 2024 ~ 2026대한췌장담도학회 췌장연구회 위원 2023 ~ 2024대한소화기암연구학회 학술위원회 위원 2022 ~ 2023대한췌장담도학회 정보위원회 위원 2020 ~ 2023대한췌장담도학회 보험위원회 위원 2018 ~ 대한소화기내시경학회 정회원, 내시경 세부전문의 2018 ~ 대한소화기암학회 평생회원, 소화기암 인정의 2018 ~ 대한췌장담도학회 평생회원, 췌장담도내시경(ERCP) 인증의/지도전문의 2014 ~ 대한내과학회 정회원, 소화기내과 분과전문의 |
수상이력
2026.09IASGO2026 Excellent Abstracts Award 2026.09대한췌장담도학회 학술연구비 선정 2023.03과학기술정보통신부 개인기초연구사업 연구비 선정 2023.01대한소화기암연구학회 학술연구비 선정 2022.04Seoul International Digestive Disease Symposium (SIDDS) 우수연구상 2020.08대한췌장담도학회(IC-KBPA 2020) 우수구연상 2019.09대한췌장담도학회 추계학술대회 우수포스터상 2018.11대한소화기내시경학회 우수논문상 |
논문
1. Shin DW, Ahn JS, Song H, Moon SH, et al. Chemotherapy for Older Adults with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. J Clin Med. 2026;15(6):2254.
2. Shin DW, Cho JY, Cho S, Youn Y, Hwang JH. Development of a serum protein biomarker panel for the diagnosis of pancreatic ductal adenocarcinoma using a machine learning approach. Sci Rep. 2025;15:35659.
3. Shin DW, Cho YA, Moon SH, Kim TH, Park JW, Lee JW, et al. High cellular prion protein expression in cholangiocarcinoma: A marker for early postoperative recurrence and unfavorable prognosis. World J Gastrointest Surg. 2025;17(3):101940.
4. Shin DW. Treatment of Ampullary Adenocarcinoma. Korean J Gastroenterol. 2023;82(4):159-170.
5. Shin DW, Lee JM, Lee JC, Lee HS, Yoon SB, Jang DK, et al. Adjuvant Chemotherapy and Effect on Long-Term Survival in Ampullary Adenocarcinoma: A Multicenter Cohort Study. J Am Coll Surg. 2023;237(3):501-512.
6. Shin DW, Kim S, Jung K, Jung JH, Kim B, Ahn J, et al. Impact of histopathological type on the prognosis of ampullary carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2023;49(2):306-315.
7. Shin DW, Moon SH, Kim JH. Diagnosis of Cholangiocarcinoma. Diagnostics (Basel). 2023;13(2):233.
8. Shin DW, Park J, Lee JC, Kim J, Kim YH, Hwang JH. Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2022;14(10):2476.
9. Shin DW, Kim MA, Lee JC, Kim J, Hwang JH. Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients. BMC Res Notes. 2021;14(1):272.
10. Shin DW, Lee JC, Kim J, Yoon YS, Han HS, Kim H, et al. Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resected pancreatic ductal adenocarcinoma: A biomarker stratified prospective trial. Pancreatology. 2021;21(4):796-804.
11. Shin DW, Kim MJ, Lee JC, Kim J, Woo SM, Lee WJ, et al. Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma: A Large Multicenter Study. Am J Clin Oncol. 2020;43(6):422-427.
12. Shin DW, Kim J. The American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma: is it better than the 7th edition? Hepatobiliary Surg Nutr. 2020;9(1):98-100.
13. Shin DW, Lee JC, Kim J, Woo SM, Lee WJ, Han SS, et al. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2019;45(11):2159-2165.
14. Shin DW, Choi YJ, Kim HS, Han KD, Yoon H, Park YS, et al. Secondary Breast, Ovarian, and Uterine Cancers After Colorectal Cancer: A Nationwide Population-Based Cohort Study in Korea. Dis Colon Rectum. 2018;61(11):1250-1257.
15. Shin DW, Yoon H, Kim HS, Choi YJ, Shin CM, Park YS, et al. Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study. Evid Based Complement Alternat Med. 2018;2018:9147914.
16. Shin DW, Hwang HY, Jeon SW. Comparison of Endoscopic Submucosal Dissection and Surgery for Differentiated Type Early Gastric Cancer within the Expanded Criteria. Clin Endosc. 2017;50(2):170-178.
17. Chung KH, Paik KH, Lee YC, Choi JH, Ko SW, Son JH, et al. Clinical Practice Guideline of Korean Pancreatobiliary Association for Autoimmune Pancreatitis. Korean J Pancreas Biliary Tract. 2026;31(3):79-98.
18. Cho YA, Shin DW, Kim MJ, Park JW, Choe JY, Lee JW, et al. Clinical significance of citrullinated glial fibrillary acidic protein in predicting outcomes in hepatocellular carcinoma. World J Gastrointest Oncol. 2025;17(12):110877.
19. Jang DK, Kim SJ, Chung HH, Lee JM, Yoon SB, Lee JC, et al. Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study. Gut Liver. 2024;18(4):729-736.
20. Yoon SB, Yang MJ, Shin DW, Soh JS, Lim H, Kang HS, et al. Endoscopic ultrasound-rendezvous versus percutaneous-endoscopic rendezvous endoscopic retrograde cholangiopancreatography for bile duct access: Systematic review and meta-analysis. Dig Endosc. 2024;36(2):129-140.
21. Yoon SB, Jeon TY, Moon SH, Shin DW, Lee SM, Choi MH, et al. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Eur Radiol. 2023;33(12):9010-9021.
22. Yoon SB, Jeon TY, Moon SH, Shin DW, Park JW, Kim SE, et al. Effectiveness and complication rates of percutaneous transhepatic fluoroscopy-guided management of common bile duct stones: a single-arm meta-analysis. Eur Radiol. 2023;33(11):7398-7407.
23. Yoo JW, Jo SI, Shin DW, Park JW, Kim SE, Lim H, et al. Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn's Disease, Intestinal Tuberculosis, and Behcet's Disease. Diagnostics (Basel). 2023;13(18):2904.
24. Bae J, Shin DW, Cho KB, Ahn KS, Kim TS, Kim YH, et al. Survival outcome of surgical resection compared to non-resection for Bismuth type IV perihilar cholangiocarcinoma. Langenbecks Arch Surg. 2023;408(1):229.
25. Moon SH, Shin DW, Lim H, Jeon TY. Inadvertent double puncture of the stomach and duodenum during EUS-guided pseudocyst drainage: caution against puncturing from the gastric antrum. Gastrointest Endosc. 2023;97(6):1163-1164.
26. Yoon SB, Jung MK, Lee YS, Park JK, Jang DK, Lee JM, et al. Long-term outcomes of endoscopic papillectomy for ampullary adenoma with high-grade dysplasia or adenocarcinoma: a propensity score-matched analysis. Surg Endosc. 2023;37(5):3522-3530.
27. Uhm S, Cho YA, Choe JY, Park JW, Kim MJ, Han WH, et al. Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma. Diagnostics (Basel). 2023;13(4):659.
28. Park M, Lee JW, Shin DW, Kim J, Lee YJ, Lee JY, et al. Comparison between a novel core knife and the conventional IT knife 2 for endoscopic submucosal dissection of gastric mucosal lesions. Clin Endosc. 2022;55(6):767-774.
29. Han SY, Kim DU, Nam HS, Kang DH, Jang SI, Lee DK, et al. Comparison of the Malignant Predictors in Intrahepatic and Extrahepatic Intraductal Papillary Neoplasm of the Bile Duct. J Clin Med. 2022;11(7):1985.
30. Han JY, Ahn KS, Kim TS, Kim YH, Cho KB, Shin DW, et al. Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer. Cancers (Basel). 2021;13(18):4581.
31. Song DH, Cho IK, Shin DW, Lee JC, Cho JY, Yoon YS, et al. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer. Surg Today. 2021;51(6):978-985.
32. Hwang YJ, Shin DW, Kim N, Yoon H, Shin CM, Park YS, et al. Sex difference in bowel preparation quality and colonoscopy time. Korean J Intern Med. 2021;36(2):322-331.
33. Lee JC, Shin DW, Park H, Kim J, Youn Y, Kim JH, et al. Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial. Gastrointest Endosc. 2020;92(5):1044-1052.e1.
34. Cho JH, Yoon YS, Kim EJ, Kim YS, Cho JY, Han HS, et al. A multicenter prospective randomized controlled trial for preoperative biliary drainage with uncovered metal versus plastic stents for resectable periampullary cancer. J Hepatobiliary Pancreat Sci. 2020;27(10):690-699.
35. Lee JC, Woo SM, Shin DW, Kim J, Yang SY, Kim MJ, et al. Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry. Am J Clin Oncol. 2020;43(9):654-659.
36. Jung JH, Shin DW, Kim J, Lee JC, Hwang JH. Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment. Cancers (Basel). 2020;12(11):3137.
37. Kim HS, Yoon H, Shin DW, Oh DJ, Kwon M, Choi YJ, et al. Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Helicobacter pylori Eradication. Korean J Helicobacter Up Gastrointest Res. 2020;20(3):218-224.
38. Ahn S, Lee JC, Shin DW, Kim J, Hwang JH. High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer. Sci Rep. 2020;10(1):12348.
39. Choi YJ, Lee DH, Shin DW, Han KD, Yoon H, Shin CM, et al. Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study. Aliment Pharmacol Ther. 2019;50(7):769-779.
40. Kim HS, Choi YJ, Shin DW, Han KD, Yoon H, Shin CM, et al. Secondary Primary Prostate Cancer after Colorectal Cancer: A Nationwide Population-based Cohort Study in Korea. J Cancer Prev. 2017;22(4):241-247.
2. Shin DW, Cho JY, Cho S, Youn Y, Hwang JH. Development of a serum protein biomarker panel for the diagnosis of pancreatic ductal adenocarcinoma using a machine learning approach. Sci Rep. 2025;15:35659.
3. Shin DW, Cho YA, Moon SH, Kim TH, Park JW, Lee JW, et al. High cellular prion protein expression in cholangiocarcinoma: A marker for early postoperative recurrence and unfavorable prognosis. World J Gastrointest Surg. 2025;17(3):101940.
4. Shin DW. Treatment of Ampullary Adenocarcinoma. Korean J Gastroenterol. 2023;82(4):159-170.
5. Shin DW, Lee JM, Lee JC, Lee HS, Yoon SB, Jang DK, et al. Adjuvant Chemotherapy and Effect on Long-Term Survival in Ampullary Adenocarcinoma: A Multicenter Cohort Study. J Am Coll Surg. 2023;237(3):501-512.
6. Shin DW, Kim S, Jung K, Jung JH, Kim B, Ahn J, et al. Impact of histopathological type on the prognosis of ampullary carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2023;49(2):306-315.
7. Shin DW, Moon SH, Kim JH. Diagnosis of Cholangiocarcinoma. Diagnostics (Basel). 2023;13(2):233.
8. Shin DW, Park J, Lee JC, Kim J, Kim YH, Hwang JH. Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2022;14(10):2476.
9. Shin DW, Kim MA, Lee JC, Kim J, Hwang JH. Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients. BMC Res Notes. 2021;14(1):272.
10. Shin DW, Lee JC, Kim J, Yoon YS, Han HS, Kim H, et al. Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resected pancreatic ductal adenocarcinoma: A biomarker stratified prospective trial. Pancreatology. 2021;21(4):796-804.
11. Shin DW, Kim MJ, Lee JC, Kim J, Woo SM, Lee WJ, et al. Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma: A Large Multicenter Study. Am J Clin Oncol. 2020;43(6):422-427.
12. Shin DW, Kim J. The American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma: is it better than the 7th edition? Hepatobiliary Surg Nutr. 2020;9(1):98-100.
13. Shin DW, Lee JC, Kim J, Woo SM, Lee WJ, Han SS, et al. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2019;45(11):2159-2165.
14. Shin DW, Choi YJ, Kim HS, Han KD, Yoon H, Park YS, et al. Secondary Breast, Ovarian, and Uterine Cancers After Colorectal Cancer: A Nationwide Population-Based Cohort Study in Korea. Dis Colon Rectum. 2018;61(11):1250-1257.
15. Shin DW, Yoon H, Kim HS, Choi YJ, Shin CM, Park YS, et al. Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study. Evid Based Complement Alternat Med. 2018;2018:9147914.
16. Shin DW, Hwang HY, Jeon SW. Comparison of Endoscopic Submucosal Dissection and Surgery for Differentiated Type Early Gastric Cancer within the Expanded Criteria. Clin Endosc. 2017;50(2):170-178.
17. Chung KH, Paik KH, Lee YC, Choi JH, Ko SW, Son JH, et al. Clinical Practice Guideline of Korean Pancreatobiliary Association for Autoimmune Pancreatitis. Korean J Pancreas Biliary Tract. 2026;31(3):79-98.
18. Cho YA, Shin DW, Kim MJ, Park JW, Choe JY, Lee JW, et al. Clinical significance of citrullinated glial fibrillary acidic protein in predicting outcomes in hepatocellular carcinoma. World J Gastrointest Oncol. 2025;17(12):110877.
19. Jang DK, Kim SJ, Chung HH, Lee JM, Yoon SB, Lee JC, et al. Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study. Gut Liver. 2024;18(4):729-736.
20. Yoon SB, Yang MJ, Shin DW, Soh JS, Lim H, Kang HS, et al. Endoscopic ultrasound-rendezvous versus percutaneous-endoscopic rendezvous endoscopic retrograde cholangiopancreatography for bile duct access: Systematic review and meta-analysis. Dig Endosc. 2024;36(2):129-140.
21. Yoon SB, Jeon TY, Moon SH, Shin DW, Lee SM, Choi MH, et al. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Eur Radiol. 2023;33(12):9010-9021.
22. Yoon SB, Jeon TY, Moon SH, Shin DW, Park JW, Kim SE, et al. Effectiveness and complication rates of percutaneous transhepatic fluoroscopy-guided management of common bile duct stones: a single-arm meta-analysis. Eur Radiol. 2023;33(11):7398-7407.
23. Yoo JW, Jo SI, Shin DW, Park JW, Kim SE, Lim H, et al. Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn's Disease, Intestinal Tuberculosis, and Behcet's Disease. Diagnostics (Basel). 2023;13(18):2904.
24. Bae J, Shin DW, Cho KB, Ahn KS, Kim TS, Kim YH, et al. Survival outcome of surgical resection compared to non-resection for Bismuth type IV perihilar cholangiocarcinoma. Langenbecks Arch Surg. 2023;408(1):229.
25. Moon SH, Shin DW, Lim H, Jeon TY. Inadvertent double puncture of the stomach and duodenum during EUS-guided pseudocyst drainage: caution against puncturing from the gastric antrum. Gastrointest Endosc. 2023;97(6):1163-1164.
26. Yoon SB, Jung MK, Lee YS, Park JK, Jang DK, Lee JM, et al. Long-term outcomes of endoscopic papillectomy for ampullary adenoma with high-grade dysplasia or adenocarcinoma: a propensity score-matched analysis. Surg Endosc. 2023;37(5):3522-3530.
27. Uhm S, Cho YA, Choe JY, Park JW, Kim MJ, Han WH, et al. Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma. Diagnostics (Basel). 2023;13(4):659.
28. Park M, Lee JW, Shin DW, Kim J, Lee YJ, Lee JY, et al. Comparison between a novel core knife and the conventional IT knife 2 for endoscopic submucosal dissection of gastric mucosal lesions. Clin Endosc. 2022;55(6):767-774.
29. Han SY, Kim DU, Nam HS, Kang DH, Jang SI, Lee DK, et al. Comparison of the Malignant Predictors in Intrahepatic and Extrahepatic Intraductal Papillary Neoplasm of the Bile Duct. J Clin Med. 2022;11(7):1985.
30. Han JY, Ahn KS, Kim TS, Kim YH, Cho KB, Shin DW, et al. Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer. Cancers (Basel). 2021;13(18):4581.
31. Song DH, Cho IK, Shin DW, Lee JC, Cho JY, Yoon YS, et al. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer. Surg Today. 2021;51(6):978-985.
32. Hwang YJ, Shin DW, Kim N, Yoon H, Shin CM, Park YS, et al. Sex difference in bowel preparation quality and colonoscopy time. Korean J Intern Med. 2021;36(2):322-331.
33. Lee JC, Shin DW, Park H, Kim J, Youn Y, Kim JH, et al. Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial. Gastrointest Endosc. 2020;92(5):1044-1052.e1.
34. Cho JH, Yoon YS, Kim EJ, Kim YS, Cho JY, Han HS, et al. A multicenter prospective randomized controlled trial for preoperative biliary drainage with uncovered metal versus plastic stents for resectable periampullary cancer. J Hepatobiliary Pancreat Sci. 2020;27(10):690-699.
35. Lee JC, Woo SM, Shin DW, Kim J, Yang SY, Kim MJ, et al. Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry. Am J Clin Oncol. 2020;43(9):654-659.
36. Jung JH, Shin DW, Kim J, Lee JC, Hwang JH. Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment. Cancers (Basel). 2020;12(11):3137.
37. Kim HS, Yoon H, Shin DW, Oh DJ, Kwon M, Choi YJ, et al. Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Helicobacter pylori Eradication. Korean J Helicobacter Up Gastrointest Res. 2020;20(3):218-224.
38. Ahn S, Lee JC, Shin DW, Kim J, Hwang JH. High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer. Sci Rep. 2020;10(1):12348.
39. Choi YJ, Lee DH, Shin DW, Han KD, Yoon H, Shin CM, et al. Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study. Aliment Pharmacol Ther. 2019;50(7):769-779.
40. Kim HS, Choi YJ, Shin DW, Han KD, Yoon H, Shin CM, et al. Secondary Primary Prostate Cancer after Colorectal Cancer: A Nationwide Population-based Cohort Study in Korea. J Cancer Prev. 2017;22(4):241-247.